Oura

Private

Finnish health technology company that manufactures the Oura Ring, a wearable smart ring that tracks sleep, activity, readiness, and physiological metrics.

Ourais private — you can’t buy shares. This map shows what you can buy that moves with it, and what moves against it, with dated evidence on every connection.

ouraring.comUpdated 2026-07-29research currentmethodology 2026.07.2Relationship mapping, not a recommendation.

Refresh research

Export

Decisive takeaway

Strongest public comparable: Eli Lilly and Company (LLY) — strategic investor. Strategic investment by Eli Lilly into Oura (July 2026) to integrate Ring data with GLP-1 weight-loss drug patients, creating potential partnership revenue and validation of health platform.

Top public-market relationships

The 3 strongest routes from the full map — free preview, evidence included.

Eli Lilly and CompanyLLY · NYSE

Strategic investorstockPrice could riseEquity growthinferredsource 2026-07-17inference

21conn

What it captures: Strategic investment by Eli Lilly into Oura (July 2026) to integrate Ring data with GLP-1 weight-loss drug patients, creating potential partnership revenue and validation of health platform.
What it misses: Investment size undisclosed; Lilly's primary business remains pharmaceuticals not wearables; partnership scope currently limited to GLP-1 patient monitoring pilot.
Why the price could rise: May benefit if pharmaceutical industry broadly adopts wearable-based patient monitoring — the same strategic shift that drove Lilly's investment in connected health infrastructure.
Why the price could fall: May be harmed if GLP-1 drug market contracts due to safety concerns or competition, reducing pharmaceutical companies' willingness to invest in patient monitoring platforms.

Materiality: high · Confidence: high · Medium term (1–3 years)

View in IBKRverified 2026-07-29

Fidelity Management & Research Company LLC

Strategic investorstockPrice could riseEquity growthevidence agingsource 2025-10-20inference

11conn

What it captures: Lead investor in Oura's $900M+ October 2025 funding round, establishing Fidelity's large ownership stake and validation of valuation approaching public markets.
What it misses: Private holding with no liquid trading exposure; Fidelity's stake size and pricing undisclosed; public investors cannot directly access this position.
Why the price could fall: May be harmed if wearable technology sector multiples compress or subscription-based hardware models fall out of investor favor, reducing exit valuation.

Materiality: high · Confidence: high · Medium term (1–3 years)

View in IBKRverified 2026-07-29

Garmin Ltd.GRMN · NASDAQ

Similar business modelstockPrice could riseEquity growthinferredinference

27conn

What it captures: Closest public business model match: premium wearable hardware sales with multi-day battery life focused on fitness, sleep, and recovery analytics for health-conscious consumers.
What it misses: Garmin sells wrist-worn devices not rings, lacks recurring subscription revenue model (one-time purchase), and targets outdoor/fitness athletes more than general wellness consumers.
Why the price could rise: May benefit if consumer adoption of specialized health wearables accelerates, validating premium pricing and multi-day battery life as sustainable category drivers that lift both companies.

Materiality: high · Confidence: high · Medium term (1–3 years)

View in IBKRverified 2026-07-29

17 more relationships in the full map

5Diversified ETFs and exchange-traded products
3Advanced instruments
3Competitors and substitutes
2Real-asset and commodity exposure
2Suppliers and infrastructure providers
1Similar public companies
1Credit exposure

The full map also includes: full evidence and provenance on every route · 8 negative and hedge routes · 8 catalysts to watch · 8 what-breaks-the-thesis conditions · instrument comparisons and exports.

Create a free account to unlock 3 complete maps every month — no credit card.

Create free account See what Pro unlocks

Related companies and themes

These maps share public instruments with Oura — useful for comparing exposure or spotting concentration.

Skydio9 shared Neuralink5 shared xAI4 shared Cohere4 shared ByteDance3 shared Discord3 shared

Assumptions and limitations

Public-market exposure to a private company or theme is always indirect and partial.
Connection Scores measure relationship strength to the thesis — not expected return, quality, or a buy rating.
Directional labels describe possible economic transmission mechanisms ("may benefit if…") — they are not predictions or recommendations.
This page is impersonal research — it does not consider anyone's objectives or financial situation.

Nobody subscribes for a report.

You subscribe so you never have to re-do the report. Watch Oura and get an email when this map changes — new routes, broken theses, score moves.

See pricing